A deep learning model that simulates a clinician’s diagnostic process can accurately diagnose Alzheimer’s disease from cognitively normal patients, according to a study published July 16 in Neurocomputing.

“The CXR-risk score took as input the radiograph only. This was intended to prove a point—that a CNN can extract prognostic information embedded in the image, without any other demographic or clinical information,” wrote authors of a new study published in JAMA Network Open.

Reps. Paul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.) added an independent dispute resolution amendment to the No Surprises Act, a move the American College of Radiology described as a "crucial step" toward resolving surprise medical billing.

“The differences that we observed indicate the strong possibility that there are sex differences in the structural and functional connections in the brain, which may contribute to women’s increased risk for Alzheimer’s,” said Sepideh Shokouhi, at the Alzheimer’s Association International Conference in Los Angeles.

After looking at more than 12,500 preventative office visits included in the National Ambulatory Medical Care Survey, researchers reported that the rate of screening breast ultrasound ordering by physicians has remained low.

The American College of Radiology (ACR) has expressed “serious concerns” with the No Surprises Act— legislation geared toward ending surprise medical bills, in a July 16 statement.

Clinical decision support (CDS) tools can improve the appropriateness scores of advanced imaging orders when used in clinical practice, according to a single-center analysis published in the American Journal of Roentgenology.

Industry leaders, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Medical Imaging and Technology Alliance (MITA), hosted a Capitol Hill Briefing July 17, to discuss a bipartisan bill that would expand patient access to diagnostic radiopharmaceuticals.

A newly created three-dimensional (3D) neural network can improve the detection of pulmonary nodules on CT scans, according to a study published July 12 in PLOS ONE. 

The updated LR-5 criteria for Liver Imaging Reporting and Data System (LI-RADS) version 2018 can improve sensitivity for diagnosing small hepatocellular carcinomas (HCC) compared to LI-RADS 2017.

NorthStar Medical Radioisotopes has finished construction of its new molybdenum-99 (Mo-99) processing facility in Beloit, Wisconsin, the company announced on July 16.

The FDA has approved Bayer’s gadobutrol (Gadavist) injection for use in cardiac MRI, making it the first contrast agent approved for the imaging technique, according to a statement from Bayer.